CGEN · NASDAQ · Biotechnology

Compugen (CGEN)

Builds cancer immunotherapies from computationally predicted drug targets.

$2.65
Pre-market+0.03 (+1.00%)
At close$2.63(+1.35%)

Breakdown13F · 13D/G · Form 4

Institutions81 holders · as of Mar 31, 202615.02%14.21M ADS
Insiders12 holders · as of Jul 30, 20260.43%406.4K ADS
Strategic holders1 holder · as of Nov 19, 20215.03%4.76M ADS
Otherremainder79.52%75.18M ADS

94.55M ADS as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Nikko Asset Management Americas, Inc.Institution
7.40%7.00M13G/Afiled Feb 14, 2022
Bristol Myers Squibb CoStrategic
5.03%4.76M13Gfiled Nov 19, 2021
Silverarc Capital Management, LLCInstitution
3.51%3.32M ADS13Fas of Mar 31, 2026
Renaissance Technologies LLCInstitution
1.73%1.63M ADS13Fas of Mar 31, 2026
Morgan StanleyInstitution
1.11%1.05M ADS13Fas of Mar 31, 2026
Ark Investment Management LLCInstitution
1.11%1.05M ADS13Fas of Mar 31, 2026
Macquarie Management Holdings, Inc.Institution
1.08%1.02M ADS13Fas of Mar 31, 2026
Taylor Frigon Capital Management LLCInstitution
0.90%848,043 ADS13Fas of Mar 31, 2026
Northern Trust CorpInstitution
0.69%650,868 ADS13Fas of Mar 31, 2026
Two Sigma Investments, LPInstitution
0.55%521,587 ADS13Fas of Mar 31, 2026
State Street CorpInstitution
0.44%415,366 ADS13Fas of Mar 31, 2026
Yelin Lapidot Holdings Management Ltd.Institution
0.34%318,852 ADS13Fas of Mar 31, 2026
UBS Group AGInstitution
0.32%306,708 ADS13Fas of Mar 31, 2026
Dafna Capital Management LLCInstitution
0.27%257,783 ADS13Fas of Mar 31, 2026
Marshall Wace, LLPInstitution
0.26%244,480 ADS13Fas of Mar 31, 2026
Millennium Management LLCInstitution
0.18%168,927 ADS13Fas of Mar 31, 2026
Winton Group LtdInstitution
0.17%156,496 ADS13Fas of Mar 31, 2026
Rothschild Investment LLCInstitution
0.15%140,600 ADS13Fas of Mar 31, 2026
SRS Capital Advisors, Inc.Institution
0.14%131,800 ADS13Fas of Mar 31, 2026
Citadel Advisors LLCInstitution
0.12%112,393 ADS13Fas of Mar 31, 2026
Cresset Asset Management, LLCInstitution
0.12%111,079 ADS13Fas of Mar 31, 2026
Advisor Group Holdings, Inc.Institution
0.12%109,575 ADS13Fas of Mar 31, 2026
Anat Cohen-DayagInsiderdirector
0.11%108,622 ordinaryForm 4filed Mar 18, 2026
Raymond James Financial IncInstitution
0.11%104,889 ADS13Fas of Mar 31, 2026
Stonepine Capital Management, LLCInstitution
0.11%104,300 ADS13Fas of Mar 31, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

81 holders · 14.21M shares · 13 new positions · 32 increased · 15 reduced · 7 closed

HolderShares% outstandingChg q/qFiled
Silverarc Capital Management, LLC3.32M3.51%−164.0KMay 14, 2026
Renaissance Technologies LLC1.63M1.73%+176.1KMay 14, 2026
Morgan Stanley1.05M1.11%+43.5KMay 15, 2026
Ark Investment Management LLC1.05M1.11%+1.05MnewMay 12, 2026
Macquarie Management Holdings, Inc.1.02M1.08%0May 15, 2026
Taylor Frigon Capital Management LLC848.0K0.90%−21.2KApr 29, 2026
Northern Trust Corp650.9K0.69%−8.0KMay 14, 2026
Two Sigma Investments, LP521.6K0.55%+217.6KMay 15, 2026

Ownership statements13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Jul 9, 2026
Zurit Levineofficer: SVP, Business Development
Sale1,875$2.5029,375
Apr 24, 2026
Eran Ophirdirector, officer: President and CEO
Sale5,000$3.2011,375
Apr 24, 2026
Zurit Levineofficer: SVP, Business Development
Sale2,000$3.2029,375
Apr 14, 2026
Zurit Levineofficer: SVP, Business Development
Sale2,000$2.8029,375
Apr 14, 2026
Eran Ophirdirector, officer: President and CEO
Sale5,000$2.9011,375
Apr 10, 2026
Zurit Levineofficer: SVP, Business Development
Sale3,125$2.5629,375
Apr 7, 2026
Zurit Levineofficer: SVP, Business Development
Sale2,500$2.3029,375
Apr 8, 2026
Zurit Levineofficer: SVP, Business Development
Sale5,375$2.4229,375
Apr 1, 2026
Eran Ophirdirector, officer: President and CEO
Sale5,625$2.2111,375
Apr 1, 2026
Zurit Levineofficer: SVP, Business Development
Sale3,500$2.2029,375

CongressHouse and Senate disclosures

Not reported.